Purdue Pharma, which has made billions from the pain drug OxyContin, said it will stop promoting opioid pain drugs to doctors
NEW YORK -- The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, bowing to a key demand of lawsuits that blame the company for helping trigger the current drug abuse epidemic. Dr. Andrew Kolodny, director of opioid policy research at Brandeis University and an advocate for stronger regulation of opioid drug companies, said Purdue's decision is helpful, but that to make a real difference, other opioid drug companies have to do the same. Purdue and other opioid drugmakers and pharmaceutical distributors continue defending themselves against hundreds of local and state lawsuits seeking to hold the industry accountable for the drug overdose epidemic.
That's all there is!
At BETA we write compact articles so that they display in full when viewing our news feeds. We don't think you should have to click into every article to get great content. If you do need to dive deeper, you can always click into the article title and explore the related links.